Cargando…
2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
BACKGROUND: Bloodstream infections (BSI) cause significant morbidity and mortality in children, leading to longer hospital stays and increased healthcare costs. Recent epidemiology on national trends and pathogens in children is lacking, which could improve prevention strategies and empiric therapy...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253561/ http://dx.doi.org/10.1093/ofid/ofy210.1978 |
_version_ | 1783373524028620800 |
---|---|
author | Spaulding, Alicen B Watson, Dave Dreyfus, Jill Bendel-Stenzel, Ellen Heaton, Phillip Grapentine, Steve Kharbanda, Anupam |
author_facet | Spaulding, Alicen B Watson, Dave Dreyfus, Jill Bendel-Stenzel, Ellen Heaton, Phillip Grapentine, Steve Kharbanda, Anupam |
author_sort | Spaulding, Alicen B |
collection | PubMed |
description | BACKGROUND: Bloodstream infections (BSI) cause significant morbidity and mortality in children, leading to longer hospital stays and increased healthcare costs. Recent epidemiology on national trends and pathogens in children is lacking, which could improve prevention strategies and empiric therapy selection. METHODS: We conducted a retrospective cohort study utilizing demographic and microbiology data from the Premier Healthcare Database, including all inpatient encounters from 2009–2016 among patients <19 years. BSI were identified via a documented positive blood culture; known contaminants were excluded. Incidence rate was the number of BSI-positive patient encounters per 10,000 admissions. Demographics were analyzed comparing BSI-positive to patients without a documented positive BSI (non-BSI). Hospital-acquired infections were defined as those occurring at least 2 days after admission and analyzed only for non-neonates. Differences were assessed using chi-square tests and t-tests; time trends were analyzed using Cochran-Armitage tests. RESULTS: Among 162 US hospitals reporting ≥4 years of blood cultures, 1,809,722 patient encounters met inclusion criteria; 6,152 (0.34%) had a positive BSI. BSI patients were significantly more often 1–5 years old (16% vs. 6%), and had a complex chronic condition (26% vs. 5%), central line (34% vs. 2%), or catheter (12% vs. 3%) compared with non-BSI patients. Overall BSI incidence rate declined over time (37.0 in 2009 vs. 31.9 in 2016 per 10,000 admissions, P < 0.001). Among non-neonates, pathogens with the highest incidence rates (per 10,000 admissions) were methicillin-susceptible Staphylococcus aureus (MSSA) (10.5), E. coli (10.4), and Streptococcus pneumoniae (6.4); among neonates incidence was highest for E. coli (4.3), Group B Streptococcus (4.0) and MSSA (2.6). Incidence increased significantly over time in two US regions while decreasing in three (Figure 2). CONCLUSION: Hospitalized children remain at risk of community and hospital-acquired BSI. Due to substantial efforts, pediatric BSI incidence has declined nationally in recent years. However, more effective methods to prevent and assess patients at risk for BSI are warranted. [Image: see text] [Image: see text] DISCLOSURES: J. Dreyfus, Premier, Inc.: Employee and Shareholder, Salary. |
format | Online Article Text |
id | pubmed-6253561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62535612018-11-28 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences Spaulding, Alicen B Watson, Dave Dreyfus, Jill Bendel-Stenzel, Ellen Heaton, Phillip Grapentine, Steve Kharbanda, Anupam Open Forum Infect Dis Abstracts BACKGROUND: Bloodstream infections (BSI) cause significant morbidity and mortality in children, leading to longer hospital stays and increased healthcare costs. Recent epidemiology on national trends and pathogens in children is lacking, which could improve prevention strategies and empiric therapy selection. METHODS: We conducted a retrospective cohort study utilizing demographic and microbiology data from the Premier Healthcare Database, including all inpatient encounters from 2009–2016 among patients <19 years. BSI were identified via a documented positive blood culture; known contaminants were excluded. Incidence rate was the number of BSI-positive patient encounters per 10,000 admissions. Demographics were analyzed comparing BSI-positive to patients without a documented positive BSI (non-BSI). Hospital-acquired infections were defined as those occurring at least 2 days after admission and analyzed only for non-neonates. Differences were assessed using chi-square tests and t-tests; time trends were analyzed using Cochran-Armitage tests. RESULTS: Among 162 US hospitals reporting ≥4 years of blood cultures, 1,809,722 patient encounters met inclusion criteria; 6,152 (0.34%) had a positive BSI. BSI patients were significantly more often 1–5 years old (16% vs. 6%), and had a complex chronic condition (26% vs. 5%), central line (34% vs. 2%), or catheter (12% vs. 3%) compared with non-BSI patients. Overall BSI incidence rate declined over time (37.0 in 2009 vs. 31.9 in 2016 per 10,000 admissions, P < 0.001). Among non-neonates, pathogens with the highest incidence rates (per 10,000 admissions) were methicillin-susceptible Staphylococcus aureus (MSSA) (10.5), E. coli (10.4), and Streptococcus pneumoniae (6.4); among neonates incidence was highest for E. coli (4.3), Group B Streptococcus (4.0) and MSSA (2.6). Incidence increased significantly over time in two US regions while decreasing in three (Figure 2). CONCLUSION: Hospitalized children remain at risk of community and hospital-acquired BSI. Due to substantial efforts, pediatric BSI incidence has declined nationally in recent years. However, more effective methods to prevent and assess patients at risk for BSI are warranted. [Image: see text] [Image: see text] DISCLOSURES: J. Dreyfus, Premier, Inc.: Employee and Shareholder, Salary. Oxford University Press 2018-11-26 /pmc/articles/PMC6253561/ http://dx.doi.org/10.1093/ofid/ofy210.1978 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Spaulding, Alicen B Watson, Dave Dreyfus, Jill Bendel-Stenzel, Ellen Heaton, Phillip Grapentine, Steve Kharbanda, Anupam 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences |
title | 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences |
title_full | 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences |
title_fullStr | 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences |
title_full_unstemmed | 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences |
title_short | 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences |
title_sort | 2325. bloodstream infections in hospitalized children in the united states: incidence, pathogens, and regional differences |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253561/ http://dx.doi.org/10.1093/ofid/ofy210.1978 |
work_keys_str_mv | AT spauldingalicenb 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences AT watsondave 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences AT dreyfusjill 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences AT bendelstenzelellen 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences AT heatonphillip 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences AT grapentinesteve 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences AT kharbandaanupam 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences |